Stereotaxis (STXS) Net Cash Flow Growth (1y) (2011 - 2026)
Stereotaxis (STXS) Net Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | -9.88% |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | 131.47% |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | - |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | -47.85% |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | -40.20% |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | -196.55% |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | -41.07% |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | 102.38% |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | 84.02% |
| 10 | Stereotaxis | 128.56 Mn | 113.94 Mn | 3.79 Mn | 168.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 168.40% |
| Dec 31, 2025 | 104.85% |
| Sep 30, 2025 | 185.26% |
| Jun 30, 2025 | -20.88% |
| Mar 31, 2025 | 24.57% |
| Dec 31, 2024 | 158.97% |
| Sep 30, 2024 | -336.03% |
| Jun 30, 2024 | -117.82% |
| Mar 31, 2024 | 25.17% |
| Dec 31, 2023 | 89.31% |
| Sep 30, 2023 | 64.61% |
| Jun 30, 2023 | 1,092.31% |
| Mar 31, 2023 | 6.01% |
| Dec 31, 2022 | -839.10% |
| Sep 30, 2022 | -95.92% |
| Jun 30, 2022 | -4,652.63% |
| Mar 31, 2022 | -5,677.19% |
| Dec 31, 2021 | -799.48% |
| Sep 30, 2021 | -234.61% |
| Jun 30, 2021 | -99.76% |